The Minnesota Coronary Survey was a 4.5-year, open enrollment, single end-time, double-blind, randomized clinical trial that was conducted In six Minnesota state mental hospitals and one nursing home. It Involved 4393 Institutionalized men and 4664 Institutionalized women. The trial compared the effects of a 39% fat control diet (18% saturated fat, 5% polyunsaturated fat, 16% monounsaturated fat, 446 mg dietary cholesterol per day) with a 38% fat treatment diet (9% saturated fat, 15% polyunsaturated fat, 14% monounsaturated fat, 166 mg dietary cholesterol per day) on serum cholesterol levels and the Incidence of myocardlal Infarctions, sudden deaths, and all-cause mortality. The mean duration of time on the diets was 384 days, with 1568 subjects consuming the diet for over 2 years. The mean serum cholesterol level In the pre-admission period was 207 mg/dl, falling to 175 mg/dl in the treatment group and 203 mg/dl In the control group. For the entire study population, no differences between the treatment and control groups were observed for cardiovascular events, cardiovascular deaths, or total mortality. A favorable trend for all these end-points occurred In some younger age groups. (Arteriosclerosis 9:129-135, January/February 1989) T he institutions chosen for the trial were the Minnesota state mental hospitals at Anoka, Fergus Falls, Hastings, Moose Lake, St. Peter, and Willmar and the nursing home at Oak Terrace. Before initiation of the experimental phase, the populations were observed for a 3-year period, during which their suitability for a long-term dietary trial was studied. The feeding program began in the Willmar State Hospital in November, 1968. The program was phased in to the other institutions in succession over the following 15 months. The trial was an outgrowth of the National Diet-Heart Feasibility Study.
T he institutions chosen for the trial were the Minnesota state mental hospitals at Anoka, Fergus Falls, Hastings, Moose Lake, St. Peter, and Willmar and the nursing home at Oak Terrace. Before initiation of the experimental phase, the populations were observed for a 3-year period, during which their suitability for a long-term dietary trial was studied. The feeding program began in the Willmar State Hospital in November, 1968. The program was phased in to the other institutions in succession over the following 15 months. The trial was an outgrowth of the National Diet-Heart Feasibility Study. 1 
Methods

Ethical Considerations
The project was approved by the Clinical Research Committee of the University and, after extensive discussion with the relevant institutional committees, by each of the collaborating hospitals. No consent forms were required on the grounds that the two diets were both acceptable as house diets and the tests all contributed to better patient care. Before initiation of the study in each hospital, all the residents and staff were invited to a meeting at which the investigators explained the project. Samples of the foods were served at these meetings. There was a question and answer period, and the residents were invited to make appointments for one-to-one further explanations if they wished. They were allowed to decline to participate or to discontinue their participation at any time. Nonparticipants were served the control diet, which was similar to the pre-study institutional diets. Blood was not drawn from nonparticipants, and electrocardiograms were not recorded. Participation was nearly 100% with fewer than a dozen refusals throughout the trial.
Experimental Plan
The original population was initially stratified into 512 cells on the basis of eight variables. These were: age, sex, length of stay in the hospital, weight, blood pressure, diabetes, cigarette smoking, and evidence by electrocardiogram of a previous myocardial infarction. When new subjects were admitted later, they were divided among four cells, based on only age and sex.
Two diets were served. The control diet involved little departure from the institutional diet served before the trial. The treatment diet represented a compromise between the B and C diets of the National Diet-Heart Study, with target values of 45% of calories from fat, a polyunsaturated/ saturated fat (P/S) ratio of 2.5, and less than 150 mg of cholesterol daily.
Both diets were served in a single line. As a participant entered the line, he or she was handed a label bearing his or her name and a code number that was incomprehensible to the uninitiated but easily interpreted by the food servers to determine which diet was to be served. A new set of 21 labels was prepared by computer each week for each participant based on changes in the population during that week. The label served multiple purposes. One was to sound a personal note with the subject, one of the many positive influences which our study had on the hospitals. The label also enabled the food service worker to serve the proper tray without compromising the blind design, and the labels remaining on the sheet provided the basis for the daily tally of missed meals. Each month the hospital technicians transferred the missing meals data to a "Port-o-Punch card." These cards were read by the computer and at the end provided a correlation between adherence and cholesterol response.
Fasting blood was drawn from every patient on admission to the hospital, and at 6-month intervals thereafter. The serum was frozen and analyzed at a later date to avoid doing analyses on patients who remained in the hospital for too short a time to contribute significantly to the results. All sera from all subjects who remained in the study on either diet for at least 1 year, from every subject who died or had a cardiovascular event, and from a set of additional subjects matched on age and sex who did not have an event were analyzed. When a subject left the hospital and then returned, blood for the cholesterol determination was drawn after he had been back on the diet for 3 weeks.
Dietary Procedures
Traditional American foods were used for the control diet, and foods high in polyunsaturated fat and low in saturated fat and cholesterol were used for the experimental diet. Baseline dietary data were obtained by chemical analysis of composites of a 21-day food collection conducted at all hospitals during the pre-diet period. The experimental diet goal was to provide 18% to 20% of calories from polyunsaturated fat, to limit saturates to less than 9%, and to maintain the ratio of polyunsaturated to saturated fats at more than 2:1. Cholesterol was to be as low as could be achieved without sacrificing palatability (150 mg per day or less). Specifications and 4-year average values are shown in Table 1 . Figures 1 and 2 are plots of seven hospital averages of the P/S ratio and the dietary cholesterol content, respectively, measured at yearly intervals over a 4-year period. Table 2 shows the content of the diets for some of the more important nutrients and minerals.
Procurement of suitable foods for the treatment diet, (with the desired polyunsaturated fat, which were yet palatable, stable, and indistinguishable from the corresponding components of the control diet) presented a great challenge. It was achieved through cooperation of the study nutritionists, the hospital dietitians, manufactur- ers of food products, and the Food Inspection Division of the Minnesota Department of Agriculture. Products that proved particularly useful were filled milk and ice cream, a whole egg substitute, soft margarine, whipped topping, filled cheese, low fat ground beef with added vegetable oil, and filled sausage products.
Laboratory Methods
Blood was drawn under fasting conditions. The serum was sealed in glass ampules under nitrogen, and stored at -20°C. Analyses were carried out for total cholesterol and triglycerides by the standard protocol of the LJpid Research Clinics. 2 The laboratory was standardized and monitored by the Centers for Disease Control in Atlanta. tHandbook analysis values are for the control diet. All modified foods (whole egg substitute, filled dairy products, and filled processed meats) were formulated to provide nutrient levels comparable to the standard products. Heat-stable lactate dehydrogenase was measured in the laboratory of Paul E. Strandjord. Electrocardiograms were read by Naip Tuna (Chief of Electrocardiography at the University of Minnesota Hospitals) and also by technicians in the Laboratory of Physiological Hygiene who were supervised by Henry Blackburn. Any discrepancies between the two readings were resolved by consultation between readers. The records were classified according to the Minnesota Code. 4 
Ascertainment of Cardiovascular Events
Three electrocardiograms were recorded on days 1, 3, and 7 after every suspected event. Blood was drawn at 1, 2, 3, and 4 days for measurement of total and heat-stable lactic dehydrogenase. Historical data were recorded by our technicians after consultation with the attending physician. In addition, an electrocardiogram was recorded routinely on all subjects on admission to the hospital and at intervals of 6 months for the detection of silent myocardial infarctions. When subjects returned after an absence from the hospital, an electrocardiogram was recorded if more than 6 months had elapsed since the last tracing. The autopsy percentage was maintained as high as possible. The overall percentage for persons in the trial was 57.1%. The reasons for failure to perform autopsies was almost always refusal by relatives or inability to contact relatives. The aorta, heart, and brain were fixed at the institution and were sent for study according to protocol by cardiac and neuropathologists at the University.
The principal investigator visited each of the institutions at frequent intervals and reviewed under masked conditions the hospital charts, the records kept by the trial technicians, the autopsy reports, and the laboratory data (but not the lipid analyses) on all patients who had died or who had had a suspected cardiovascular event since his last visit. He consulted with the responsible physician, if 
Data Management
Fifteen forms were devised for recording the data from the hospitals and laboratories. The data were transferred to magnetic tape to facilitate day-to-day management of the project and for later analysis. Figure 3 shows the average serum cholesterol concentrations at 6-month intervals over the duration of the study. The abscissa represents time on diet, rather than calendar months. More persons are included, therefore, at the shorter time intervals. The average fall in cholesterol for the control group was 0.7%, and for the treatment group, 14.5%. The difference between the two groups was virtually constant from 6 months onward. Figure 4 shows the smaller, but definite, difference in plasma triglycerides.
Results
The monitoring of missed meals was effective, as indicated by the relationship between adherence and missed meals. Persons assigned to the treatment diet who missed fewer than 5% of their meals during the 3 weeks before their semi-annual blood sample showed an average decrease in plasma cholesterol of 15.4% compared with their control measurement. If more than 5% of meals were missed, the decrease was 11.4% and it deteriorated progressively to 8.9% and 6.2%, respectively, if 20% or 50% of meals were missed. When persons failed to go through the serving line, they presumably ate elsewhere, although some routinely skipped breakfast.
The total number of participants in the study categorized by age and sex is shown in Table 3 . The total number of hospital stays was 11 920. The average length of each hospital stay was 292 days. The average total time in the hospital for each participant, including multiple admissions, was 384 days. Hospital stays totaled 6005 for 100- the treatment group and 5915 for the controls. Of these, only 2668 were for more than 1 year. The number of person-years of observation was 9538, with 5903 of these for persons in the hospital continuously for more than 2 years and 2495 for more than 4 years. Table 4 shows the number of occurrences of the primary end-points-acute myocardial infarctions, sudden deaths, and silent myocardial infarctions-for men and women of all ages, classified according to time in hospital. A few more events occurred in the treated group. The data are presented in life table form in Figure 5 . The similarity of the two curves is striking. Similar data for deaths from all causes are presented in Table 5 and Figure 6 . The small difference between the two life tables is in an unfavorable direction.
When the study was initiated, we suspected that any favorable outcome would be confined to the younger participants in most of whom severe atherosclerosis would not yet be present. It also seemed likely that a fair length of time would be required for the diet to exert an effect. In two recently reported drug trials, the LJpid Research Clinics Primary Prevention Trial 67 and the Helsinki Heart Study, 8 2 years were required before favorable trends appeared. Therefore, it is of some interest to look for trends in persons on the diets for at least 2 years who fell in the age ranges chosen for those studies (35 to 59 and 45 to 55 years old, respectively). Such an analysis is presented in Table 6 . If total time in hospital including multiple admissions is counted in arriving at the numbers on the diets for more than 2 years, only one more death and no more cardiovascular events are identified in the 35 to 59 year age group. In men younger than 50 years, there were three events and two deaths in the treatment group. In the control group, there were 11 events and 12 deaths. Table 7 shows the causes of death for all participants who died during the study.
Discussion
The data were viewed in many other ways. For example, persons who had a poor cholesterol response or whose initial electrocardiogram showed evidence of a previous myocardial infarction were omitted from the study. Other combinations of end-points were examined. Subsequent events after the initial one in a given subject were disregarded. None of these maneuvers changed the conclusions.
Although this study did not show a statistically significant reduction in cardiovascular events or total deaths from the treatment diet, the authors suspect that it might have shown such a reduction if the period of treatment had been longer in persons in the age range likely to benefit. We included persons of all ages, both men and women, with an average cholesterol concentration of 207 mg/dl, compared to about 290 mg/dl for the participants in the Helsinki and Upid Research Clinics trials. When the study was first proposed, very lengthy stays in mental hospitals were common. By the end of the initial 3-year pre-treatment observation period, the practice of vigorous drug treatment and early discharge to the community was in full swing. Table 6 , in which the analysis is confined to persons on diet for at least 2 years and in the age groups chosen for recent drug trials, shows some favorable trends, but the numbers are far too small to achieve statistical significance.
